Product Information
MINZOYA-28 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $3.4421 per EA under NDC 70748032214. Its NADAC has been published 76 times since Mar 12, 2025.
FDA first approved this application on Feb 15, 2024. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748032214
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA217087FDA Approved
2/15/2024
TE Code
AB3
On Market Since
1/9/2025
Price Statistics
The NADAC for MINZOYA-28 TABLET has been published 76 times since Mar 12, 2025, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4421 per EA |
|---|---|
| All-time high | $5.8495 (May 14, 2025) |
| All-time low | $3.4240 (Jul 22, 2026) |
| 52-week high | $5.2480 |
| 52-week low | $3.4240 |
| Median price | $4.9967 |
| Average price | $4.9218 |
| Largest weekly change | -9.3% (May 20, 2026) |
| Weeks tracked | 76 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levonorgestrel and ethinyl estradiol and ferrous bisglycinate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MINZOYA-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MINZOYA-28 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $3.4421 per EA (NDC 70748032214), effective Aug 19, 2026.
How has the price of MINZOYA-28 TABLET changed over time?
Over the history we have for it, the NADAC for MINZOYA-28 TABLET has declined 36.7%. It has been tracked across 76 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for MINZOYA-28 TABLET?
Since Mar 12, 2025, the NADAC for MINZOYA-28 TABLET has ranged from a low of $3.4240 (Jul 22, 2026) to a high of $5.8495 (May 14, 2025), with a median of $4.9967 per EA.
Are there cheaper alternatives to MINZOYA-28 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MINZOYA-28 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MINZOYA-28 TABLET?
MINZOYA-28 TABLET (NDC 70748032214) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.